IDSA works independently and through coalitions with like-minded organizations to monitor and favorably impact immunization policy and programs as well as to support continued investments in vaccine research and development which is essential to bring new and improved vaccines to market. U.S. policymakers must be vigilant in working to improve and ensure the availability of these critical public health tools.
While the United States has made significant progress toward eliminating vaccine-preventable diseases among children, similar successes have not yet occurred for adults and adolescents. Unacceptably low immunization rates exist among many adults and adolescents in the U.S. To combat this failure, IDSA developed a set of policy principles and recommendations to strengthen adult and adolescent immunizations, and we are working with federal and state partners to move these ideas forward.
Healthcare personnel (HCP) are at risk for exposure to vaccine-preventable diseases and possible transmission to patients, their families, other personnel, and local communities. IDSA supports mandatory immunization of HCP according to recommendations of the Advisory Committee for Immunization Practices (ACIP) of the U.S. Centers for Disease Control and Prevention (CDC).